Classification and basic pathology of Alzheimer disease

被引:773
作者
Duyckaerts, Charles [1 ,2 ,3 ]
Delatour, Benoit [3 ]
Potier, Marie-Claude [3 ]
机构
[1] Univ Paris, Hop La Pitie Salpetriere, APHP, Lab Neuropathol Escourolle, F-75651 Paris 13, France
[2] Univ Paris, Univ Paris 06, F-75651 Paris 13, France
[3] Ctr Rech Inst Cerveau & Moelle, CNRS, INSERM, Team 103,UMRS 975,UMR 7225, Paris, France
关键词
AMYLOID-BETA-PROTEIN; PAIRED HELICAL FILAMENTS; TANGLE PREDOMINANT FORM; SENILE PLAQUE NEURITES; NEOCORTICAL NEUROFIBRILLARY TANGLES; HEREDITARY CEREBRAL-HEMORRHAGE; ENTORHINAL CORTEX NEURONS; DOWNS-SYNDROME BRAINS; INTRACELLULAR A-BETA; LEWY BODY PATHOLOGY;
D O I
10.1007/s00401-009-0532-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The lesions of Alzheimer disease include accumulation of proteins, losses of neurons and synapses, and alterations related to reactive processes. Extracellular A beta accumulation occurs in the parenchyma as diffuse, focal or stellate deposits. It may involve the vessel walls of arteries, veins and capillaries. The cases in which the capillary vessel walls are affected have a higher probability of having one or two apo epsilon 4 alleles. Parenchymal as well as vascular A beta deposition follows a stepwise progression. Tau accumulation, probably the best histopathological correlate of the clinical symptoms, takes three aspects: in the cell body of the neuron as neurofibrillary tangle, in the dendrites as neuropil threads, and in the axons forming the senile plaque neuritic corona. The progression of tau pathology is stepwise and stereotyped from the entorhinal cortex, through the hippocampus, to the isocortex. The neuronal loss is heterogeneous and area-specific. Its mechanism is still discussed. The timing of the synaptic loss, probably linked to A beta peptide itself, maybe as oligomers, is also controversial. Various clinico-pathological types of Alzheimer disease have been described, according to the type of the lesions (plaque only and tangle predominant), the type of onset (focal onset), the cause (genetic or sporadic) and the associated lesions (Lewy bodies, vascular lesions, hippocampal sclerosis, TDP-43 inclusions and argyrophilic grain disease).
引用
收藏
页码:5 / 36
页数:32
相关论文
共 357 条
  • [1] IMMUNOCHEMICAL IDENTIFICATION OF THE SERINE PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN IN THE BRAIN AMYLOID DEPOSITS OF ALZHEIMERS-DISEASE
    ABRAHAM, CR
    SELKOE, DJ
    POTTER, H
    [J]. CELL, 1988, 52 (04) : 487 - 501
  • [2] Severely dystrophic axons at amyloid plaques remain continuous and connected to viable cell bodies
    Adalbert, Robert
    Nogradi, Antal
    Babetto, Elisabetta
    Janeckova, Lucie
    Walker, Simon A.
    Kerschensteiner, Martin
    Misgeld, Thomas
    Coleman, Michael P.
    [J]. BRAIN, 2009, 132 : 402 - 416
  • [3] Akiyama H, 1999, GLIA, V25, P324, DOI 10.1002/(SICI)1098-1136(19990215)25:4<324::AID-GLIA2>3.0.CO
  • [4] 2-5
  • [5] Staging of neurofibrillary pathology in Alzheimer's disease:: A study of the BrainNet Europe consortium
    Alafuzoff, Irina
    Arzberger, Thomas
    Al-Sarraj, Safa
    Bodi, Istvan
    Bogdanovic, Nenad
    Braak, Heiko
    Bugiani, Orso
    Del-Tredici, Kelly
    Ferrer, Isidro
    Gelpi, Ellen
    Giaccone, Giorgio
    Graeber, Manuel B.
    Ince, Paul
    Kamphorst, Wouter
    King, Andrew
    Korkolopoulou, Penelope
    Kovacs, Gabor G.
    Larionov, Sergey
    Meyronet, David
    Monoranu, Camelia
    Parchi, Piero
    Patsouris, Efstratios
    Roggendorf, Wolfgang
    Seilhean, Danielle
    Tagliavini, Fabrizio
    Stadelmann, Christine
    Streichenberger, Nathalie
    Thal, Dietmar R.
    Wharton, Stephen B.
    Kretzschmar, Hans
    [J]. BRAIN PATHOLOGY, 2008, 18 (04) : 484 - 496
  • [6] Inter-laboratory comparison of neuropathological assessments of β-amyloid protein:: a study of the BrainNet Europe consortium
    Alafuzoff, Irina
    Pikkarainen, Maria
    Arzberger, Thomas
    Thal, Dietmar R.
    Al-Sarraj, Safa
    Bell, Jeanne
    Bodi, Istvan
    Budka, Herbert
    Capetillo-Zarate, Estibaliz
    Ferrer, Isidro
    Gelpi, Ellen
    Gentleman, Stephen
    Giaccone, Giorgio
    Kavantzas, Nikolaos
    King, Andrew
    Korkolopoulou, Penelope
    Kovacs, Gabor G.
    Meyronet, David
    Monoranu, Camelia
    Parchi, Piero
    Patsouris, Efstratios
    Roggendorf, Wolfgang
    Stadelmann, Christine
    Streichenberger, Nathalie
    Tagliavini, Fabricio
    Kretzschmar, Hans
    [J]. ACTA NEUROPATHOLOGICA, 2008, 115 (05) : 533 - 546
  • [7] CELL LOSS IN THE NUCLEUS-RAPHES-DORSALIS IN ALZHEIMERS-DISEASE
    ALETRINO, MA
    VOGELS, OJM
    VANDOMBURG, PHMF
    TENDONKELAAR, HJ
    [J]. NEUROBIOLOGY OF AGING, 1992, 13 (04) : 461 - 468
  • [8] Focal cortical presentations of Alzheimer's disease
    Alladi, S.
    Xuereb, J.
    Bak, T.
    Nestor, P.
    Knibb, J.
    Patterson, K.
    Hodges, J. R.
    [J]. BRAIN, 2007, 130 : 2636 - 2645
  • [9] TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
    Amador-Ortiz, Catalina
    Lin, Wen-Lang
    Ahmed, Zeshan
    Personett, David
    Davies, Peter
    Dara, Ranjan
    Graff-Radford, Neill R.
    Hutton, Michael L.
    Dickson, Dennis W.
    [J]. ANNALS OF NEUROLOGY, 2007, 61 (05) : 435 - 445
  • [10] Amador-Ortiz Catalina, 2008, Handb Clin Neurol, V89, P569, DOI 10.1016/S0072-9752(07)01253-5